RxDoctor Payments Data

Howard Schertzinger, MD

Sports Medicine · Florence, KYNPI 1992797922

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $125,687 of the $147,233 with a category attached, or 85.4%. Amgen accounts for 99.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $64,276 and has fallen 100.0% since, to $23 in 2025. Among sports medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$147,233in general payments, 2019–2025

Across 344 payments — averaging $428.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$146K
  • Radius Health, Inc.$589
  • Relievant Medsystems, Inc.$158
  • Pacira Therapeutics, Inc.$70

What the payments were for

  • Speaking & faculty fees$125,68785%
  • Travel & lodging$15,39110%
  • Food & beverage$6,0774%
  • Education$790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$147,233 in reported general payments places this provider in the 95th percentile of 59 sports medicine providers in Kentucky.

See all sports medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$180,748
Medicare patients
574
Services billed
3,542

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide49$136,234
ForteoTeriparatide14$60,633
Celecoxib328$11,407
Diclofenac Sodium1,219$11,219
Nabumetone621$6,001
Tizanidine Hcl1,225$4,999
Gabapentin275$2,251
Etodolac57$1,753
Methylprednisolone273$1,586
Ultra-Fine Short Pen NeedlePen Needle, Diabetic20$1,121
Prednisone274$1,028
Tramadol Hcl318$798
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen155$790
Meloxicam139$706
Alendronate Sodium98$691

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$589$136,23449 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 59 sports medicine providers in Kentucky.

Other sports medicine in Florence

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →